Physician

Geetha Palaniappan, M.D.

According to 2025 Medicare claims, Geetha Palaniappan, M.D. (NPI: 1376638668) practices medical oncology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY WEST, PC (NPI: 1932178530; TIN: 470754790) and primary practice location at 68046-5706. Palaniappan is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), Main Street Rural Health Maple ACO LLC (ACO ID: A5401), Main Street Rural Health Hawthorn ACO LLC (ACO ID: A5438), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Palaniappan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 665 traditional Medicare patients, billed 134,102 HCPCS/CPT codes, and received $2,140,751 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,297 prescription claims across 267 beneficiaries totaling $1,628,261 in drug costs, led by Revlimid (Lenalidomide). DME data shows 15 claims. Open Payments data shows 9 records totaling $14,643. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $216,783 to $1,628,261. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $6,118 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	767	254,393	$1,547,195
2016	753	207,360	$1,641,628
2017	758	213,473	$1,972,121
2018	779	201,345	$2,205,424
2019	746	149,423	$2,221,426
2020	710	140,868	$2,103,863
2021	753	97,173	$1,492,334
2022	756	136,516	$1,687,444
2023	671	92,561	$1,365,227
2024	665	134,102	$2,140,751

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	108	432	$216,783
2016	115	545	$196,536
2017	138	809	$687,520
2018	184	1,054	$836,447
2019	187	1,028	$819,329
2020	175	956	$615,827
2021	208	1,042	$627,363
2022	224	1,116	$876,487
2023	236	1,187	$1,025,210
2024	267	1,297	$1,628,261

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	81	$5,955
2016	N/R	27	$906
2017	N/R	11	$6,013
2018	N/R	26	$4,790
2019	N/R	38	$2,975
2020	N/R	N/R	N/R
2021	N/R	23	$988
2022	11	15	$999
2023	N/R	29	$8,067
2024	N/R	15	$609

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	514	1,126	$84
86300	Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3	108	283	$20
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	199	236	$12
80053	Blood test, comprehensive group of blood chemicals	344	951	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	373	1,122	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	11	308	$272,043
Jakafi	Ruxolitinib Phosphate	12	360	$210,033
Kisqali	Ribociclib Succinate	12	336	$204,245
Calquence	Acalabrutinib Maleate	14	420	$190,282
Imbruvica	Ibrutinib	13	364	$187,559

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	15	$609

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$90	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$14,553	JAZZ PHARMACEUTICALS INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Geetha Palaniappan, M.D.?

Tedicare shows public-source Medicare data for Geetha Palaniappan, M.D. (NPI 1376638668), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Geetha Palaniappan, M.D. have ACO affiliation data?

Geetha Palaniappan, M.D. is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287), Main Street Rural Health Maple ACO LLC (MSSP, ACO ID A5401), Main Street Rural Health Hawthorn ACO LLC (MSSP, ACO ID A5438), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Geetha Palaniappan, M.D.?

Geetha Palaniappan, M.D. is linked to ONCOLOGY HEMATOLOGY WEST, PC (billing NPI 1932178530) in the available physician profile data.

Does Geetha Palaniappan, M.D. have Open Payments data?

Geetha Palaniappan, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.